BlossomHill Therapeutics, Inc. · NASDAQ:BLSM
BlossomHill Therapeutics, Inc. shareholders
As of Sep 30, 2026, 36 institutions reported holding BlossomHill Therapeutics, Inc., 53.2% of its shares. Largest: Cormorant Asset Management, LP, Orbimed Advisors LLC and Perceptive Advisors LLC. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of BlossomHill Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Cormorant Asset Management, LP | 3.61M | 11.4% | new | Nov 16, 2026 |
| Orbimed Advisors LLC | 2.71M | 8.5% | new | Nov 16, 2026 |
| Perceptive Advisors LLC | 1.81M | 5.7% | new | Nov 16, 2026 |
| Vivo Capital, LLC | 1.49M | 4.7% | new | Nov 13, 2026 |
| Deerfield Management Company, L.P. | 1.45M | 4.5% | new | Nov 16, 2026 |
| JPMorgan | 1.42M | 4.5% | new | Nov 12, 2026 |
| Janus Henderson | 1.34M | 4.2% | first report | Nov 16, 2026 |
| Fidelity | 1.03M | 3.2% | new | Nov 10, 2026 |
| Vanguard | 508K | 1.6% | new | Nov 13, 2026 |
| NEXTBio Capital Management LP | 250K | 0.79% | new | Nov 13, 2026 |